By combining kinomic analysis in vitro and in vivo, Zhao and coworkers recently identified a PI3K/AKT/mTOR-ILK (integrin β1-linked kinase) axis as a central hub for TME-MCL tumor cell interactions for both innate and acquired resistance. This evidence concerns the gene AKT1 and mantle cell lymphoma.